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CASE REPORT Open Access
Tremor after long term lithium treatment; is
it cortical myoclonus?
Ptolemaios Georgios Sarrigiannis1* , Panagiotis Zis1, Zoe Charlotte Unwin1, Daniel J. Blackburn2, Nigel Hoggard3,
Yifan Zhao4, Stephen A. Billings5, Aijaz A. Khan2, John Yianni6 and Marios Hadjivassiliou2
Abstract
Introduction: Tremor is a common side effect of treatment with lithium. Its characteristics can vary and when less
rhythmical, distinction from myoclonus can be difficult.
Methods: We identified 8 patients on long-term treatment with lithium that developed upper limb tremor. All
patients were assessed clinically and electrophysiologically, with jerk-locked averaging (JLA) and cross-correlation
(CC) analysis, and five of them underwent brain MRI examination including spectroscopy (MRS) of the cerebellum.
Results: Seven patients (6 female) had action and postural myoclonus and one a regular postural and kinetic
tremor that persisted at rest. Mean age at presentation was 58 years (range 42–77) after lengthy exposure to lithium
(range 7–40 years). During routine monitoring all patients had lithium levels within the recommended therapeutic
range (0.4-1 mmol/l). There was clinical and/or radiological evidence (on cerebellar MRS) of cerebellar dysfunction in
6 patients. JLA and/or CC suggested a cortical generator of the myoclonus in seven patients. All seven were on
antidepressants and three additionally on neuroleptics, four of them had gluten sensitivity and two reported
alcohol abuse.
Conclusions: A synergistic effect of different factors appears to be contributing to the development of cortical
myoclonus after chronic exposure to lithium. We hypothesise that the cerebellum is involved in the generation of
cortical myoclonus in these cases and factors aetiologically linked to cerebellar pathology like gluten sensitivity and
alcohol abuse may play a role in the development of myoclonus. Despite the very limited evidence in the literature,
lithium induced cortical myoclonus may not be so rare.
Keywords: Lithium, Cerebellar ataxia, Cortical myoclonus, Gluten sensitivity, JLA, MRS
Introduction
Lithium induced tremor is a common side effect and can
occur both early and after many years of exposure. When
manifesting early it usually consists of a fine tremor that
can occur at rest, be postural and/or kinetic, often unre-
lated to blood levels [1–10]. Myoclonus is another move-
ment disorder manifesting during treatment with lithium
[11]. When myoclonus presents as a tremor it can be
challenging to clinically recognise, particularly when not
stimulus sensitive. Typically tremor consists of regular
(frequency and amplitude) stereotyped repetitive move-
ments [12]. Shibasaki and Hallett make the argument that
electrophysiology is essential in the diagnosis of myoclo-
nus because “… myoclonus is difficult to distinguish from
other involuntary movements such as tremor, chorea, and
dystonia” and “… cortical myoclonus frequently appears
to be rhythmic” [13]. Although myoclonic movements are
usually assumed to be “sudden, brief and shock like” some
forms of myoclonus may fit into the broad definition of
tremor [14]. The importance of electrophysiology in dis-
tinguishing tremor from myoclonus is also highlighted by
Caviness and Brown [15]. As distinction between tremor
and myoclonus can be difficult in the clinical setting, poly-
graphy recordings and electrophysiological analysis that
are only available in specialised centres, can assist in the
classification [16] and identification of the anatomical
generator of the myoclonus.
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In cortical myoclonus, a paroxysmal depolarisation shift
(PDS) involving the cerebral motor cortex, drives the cor-
ticospinal volley that generates the myoclonic discharge
[13, 17]. The cortical spikey EEG correlate of the PDS var-
ies in morphology and can be negative if the PDS is widely
distributed across the neocortex or positive if restricted in
the deep layers of the motor cortex [18]. On the other
hand, centrally driven tremors are characterised by a
widely distributed tremorogenic network and quantitative
EEG/EMG analysis with jerk-locked averaging (JLA) and/
or cross-correlation (CC) is not expected to produce sharp
cortical transients before the tremulous EMG discharges.
In this work, we discuss our experience with 8 con-
secutive patients referred for electrophysiological assess-
ment of their tremulous motor manifestations whilst on
long-term treatment with lithium.
Methods
Standard protocol approvals, registrations and patient
consents
This is an observational study. Five of the patients in-
cluded in this work have been referred to the Sheffield
Ataxia Centre, Royal Hallamshire Hospital, Sheffield, UK
because of balance problems while the remaining three
cases were seen at a general neurology clinic primarily be-
cause of upper limb tremor. The South Yorkshire Re-
search Ethics Committee has confirmed that no ethical
approval is required given that all investigations were
clinically indicated and did not form part of a research
study. The specialised electrophysiological recordings and
quantitative analysis are routinely performed at the
Department of Clinical Neurophysiology at the Royal
Hallamshire Hospital (Sheffield, UK) and all patients
have provided written consent.
Case selection
Eight consecutive cases on chronic treatment with Lithium
referred to the department of Clinical Neurophysiology at
the Royal Hallamshire Hospital (Sheffield, UK) for
analysis of their tremulous manifestations were identi-
fied for this report.
Neuroimaging
Five of the patients (Table 1, cases 1–5) underwent brain
MRI and magnetic resonance spectroscopy (MRS) of the
vermis and the hemispheres [19]. This latter technique
is very useful in providing evidence of cerebellar dys-
function independently from the presence of atrophy
Table 1 Electroclinical and neuroimaging findings
Case no Age at onset
(Gender)
Years on
lithium
Gluten
sensitivity
Cerebellar MRS JLA & CCc SEPs Postural tremore
frequency
Psychotropic
medication
daily doses
1 77y, F 40y – Reduced NAA/Cra
vermis 0.91
hemispheres 0.78
Action and
stimulus reflex
cortical myoclonus
“Giant” & C-reflexesb 14 Hz Lithiumd 400 mg
Mirtazapine 45 mg
2 63y, F 10y + IgG Reduced NAA/Cr
vermis 0.87
hemispheres 1.04
Cortical myoclonus normal 10 Hz Lithium 400 mg
Mirtazapine 45 mg
Sertraline 200 mg
3 57y, M 7y + IgG Reduced NAA/Cr
vermis 0.79
hemispheres 1.04
Cortical myoclonus normal 10 Hz Lithium 408 mg
Venlafaxine 225 mg
4 47y, F 10y – Reduced NAA/Cr
vermis 0.75
hemispheres 0.8
Cortical myoclonus normal 11 Hz Lithium 800 mg
imipramine 100 mg
Olanzapine 25 mg
5 55y, F 30y + IgG Reduced NAA/Cr
vermis 0.89
hemispheres 0.85
Cortical myoclonus normal 10 Hz and first
harmonic at 20 Hz
Lithium 675 mg
Citalopram 40 mg
Quetiapine 100 mg
6 70y, F 20y + IgG ND Cortical myoclonus normal 8 Hz Lithium 400 mg
fluoxetine 40 mg
7 42y, F 10y – ND Cortical myoclonus normal 13 Hz Lithium 1000 mg
Quetiapine 650 mg
Sertraline 100 mg
8 66y, M 29y – ND Central tremor normal 6 Hz and first
harmonic at 12 Hz
Lithium 800 mg
Flupenthixole 0.5 mg
MRS Magnetic resonance spectroscopy, ND not done, SEP somatosensory evoked potentials
aThe NAA/Cr, N-acetyl-aspartate/creatine. This was measured in the vermis and cerebellar hemispheres (normal values Vermis > 0.95,
hemispheres > 1.00
bThe P1N2 and the P1N3 components were enlarged, above 14 μV (Fig. 1b)
cJLA, jerk locked averaging and CC, cross correlation analysis were applied in cases 1–8, results are shown in Figs. 1, 2, 3 and 4
dAll patients had lithium serum levels within the normal range: 0.4-1 mmol/L and all received a dose below 1200mg/die of lithium carbonate or
equivalent dose of lithium citrate (liquid preparation)
eCases 1 to 7 presented with a quasi-regular tremor while case 8 was rhythmical. Frequencies were estimated with the in-built FFT function in spike 2
software on 20 s epochs of EMG recordings during upper limb maintenance of anti-gravity posture
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[20–22]. The N-acetyl-aspartate/creatine, NAA/Cr, ratio
is used in our institution and the Standardized normal
values are NAA/Cr > 0.95 in the vermis and > 1.00 in the
hemispheres [19].
Electrophysiological assessment
All patients underwent electroencephalographic (EEG) and
multichannel surface electromyography (EMG) polygraphy
recordings to assess their upper limb tremulous activity.
When rhythmical sinusoidal oscillations were seen (eas-
ily appreciated from appropriately placed hand acceler-
ometers) then weight loading was used to identify a
load-invariant EMG peak that suggests a central oscillator.
The multichannel Natus Quantum amplifier (Optima
Medical Ltd) at a sampling rate of 2048Hz was used for
all EEG/EMG polygraphy examinations (analogue band-
width 0.01–680Hz). Subsequently, data was exported for
quantitative analysis on spike 2 (version 8.12) software
(CED Ltd). Fast fourier transform (FFT) analysis was per-
formed in one patient (case 8) before and after weight
loading at the level of the wrist, to distinguish between
peripheral and central components of the tremorogenic
network [23]. The techniques of jerk-locked averaging
(JLA) and cross-correlation (CC) analysis were applied in
all cases. The in-built Spike 2 software functions for data
averaging and correlation analysis, the latter averaging
technique appears in previous publications as cumulant
density [24, 25], were used. The technique of JLA was ap-
plied based on previous reports [13, 26–28] and EMG
channels were rectified and direct current (DC) removed
(time constant 0.05) to identify a clear onset of the EMG
discharges. EEG data was not filtered. This enabled us to
be able to record slow pre-movement cortical potentials
that can be seen during participation of voluntary control
systems in movement generation [27]. Events were
marked from small duration (< 75ms) myoclonic jerks,
captured from the surface EMG electrodes. Several hun-
dred to several thousand events were used for data ana-
lysis for each patient. Both JLA and CC, another data
averaging [29] method, where applied. Somatosensory
evoked potentials (SEP) recordings were made according
to recent recommendations [30] and the possibility of cor-
tical reflexes (C-reflexes) was examined with surface EMG
electrodes in the leg and arm areas with the methodology
and normal values described in previous work [31].
Results
The demographics, age at presentation, years on lithium
during onset of neurological manifestations, gluten sen-
sitivity serology, MRS, electrophysiological findings and
psychotropic medications with daily doses are described
in Table 1.
On clinical examination, four patients (cases 1–3 and 5)
had ataxia on finger-nose and heel to sheen examination,
evidence of gait ataxia and an irregular upper limb pos-
tural and action tremor that tended to persist at rest. The
other patient had similar jerky upper limb tremor, gaze
evoked nystagmus, brisk reflexes and gait ataxia (case 4).
For the remaining three patients (cases 6–8), upper limb
jerky postural/action tremor, was the main symptom at
the time of referral for a neurological opinion. Neuro-
logical examination revealed gait ataxia in case 7 who also
had occasional jerks of the right leg. Case 8 had a family
history of tremor (mother and three of his sisters were af-
fected). Two of the eight patients (case 2 and 3) had a his-
tory of excessive alcohol intake and four had positive
antigliadin antibodies in keeping with gluten sensitivity.
Case 7 had previous gastric bypass surgery and two (case
3 and 7) were on treatment with thyroxine. Case 5 had a
past history of thyrotoxicosis treated with carbimazole but
was euthyroid at presentation.
None of the patients underwent any alterations of
their lithium dose prior to the occurrence of the tremor
and all had serum lithium levels consistently within the
recommended therapeutic range (0.4-1 mmol/l) with no
past history of lithium intoxication. All eight patients re-
ceived various antidepressants (tricyclic antidepressants
(TCA), imipramine; selective serotonin reuptake inhibi-
tors (SSRIs), sertraline, citalopram, fluoxetine; noradren-
ergic and specific serotonergic antidepressant (NaSSA),
mirtazapine; serotonin-norepinephrine reuptake inhibi-
tor (SNRI), venlafaxine), and four received antipsychotic
medication (typical antipsychotics, flupenthixole; atypical
antipsychotics, quetiapine and olanzapine).
Radiologically, cerebellar atrophy was found on MRI
in two cases, moderate (case 4) and mild (case 5), while
five out of 7 had abnormal MRS with low NAA/Cr.
On electrophysiological examination, in five of the
eight patients (cases 1–5) the EEG showed background
rhythms lying within normal limits with no clear focal
or epileptiform discharges. The EEG in case 6 was re-
markable for occasional sharp/spike and slow wave
discharges with a right frontotemporal and parietal
emphasis. A single spike/slow wave discharge occurred
in the left frontotemporal region on the record of case
7 and some non-specific bursts of slow wave activity,
mainly theta, were seen on the recording from case 8.
The background EEG of these latter two patients was
lying within normal limits. There were no electro-clin-
ical associations in any of the raw EEG/EMG polygra-
phy recordings. Results from the quantitative analysis
of the data with JLA and CC showed evidence of cor-
tical reflex myoclonus for case 1, with enlarged SEPs
(Fig. 1) and of cortical myoclonus in cases 2–7 (Figs. 2,
3 and 4b, i and ii). The technique of CC, a linear aver-
aging method that can be used for quantitative EEG/
EMG data analysis, can be particularly useful when the
differential diagnostic dilemma between tremor and
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myoclonus arises. Results from CC analysis for the only
subject (case 8) with a rather sinusoidal tremor, that
emerged after many years on treatment with lithium, and
a strong family history of essential tremor are shown in
Fig. 4 where the typical sinusoidal morphology of the
oscillations, an expression of the relatively regular ampli-
tude and frequency of the tremulous movements can be
easily appreciated. Additionally, the averaged EMG poly-
graphy data exhibit variable out of phase relationships be-
tween proximal and distal muscles despite some pairs of
antagonists show relatively in phase activation (Fig. 4, i).
Contrary to this rather regular sinusoidal appearance, the
averaged results (both with the technique of JLA and CC)
for the remaining seven patients, with cortical myoclonic
tremor, show minimal, if at all, short lived sinusoidal
morphologies before and after time 0 on the averaged
templates (Fig. 1a and c, Fig. 2c and d, Fig. 3a and b, and
Fig. 4b, i and ii).
One of the patients (case 1) had no significant improve-
ment after discontinuing treatment with lithium for 6
months. Case 2 noticed significant improvement of the
myoclonus while cerebellar spectroscopy also improved
(vermis NAA/Cr increased to 0.95 from 0.87, significant
differences > 0.05) 6 months after adopting a gluten free
diet. Another patient (case 4) showed no amelioration
after her lithium daily dose was halved (from 800 to 400
mg). For the three patients referred from general neur-
ology two with myoclonus, experienced mild disability
and it was decided to follow them up without any changes
of their psychoactive medication regime. The single pa-
tient with tremor was offered a beta blocker based on
previous recommendations [32].
Fig. 1 a EEG/EMG polygraphy showing the irregular myoclonic tremor. The most prominent myoclonic jerks involve synchronously both
upper limbs and proximal and distal muscles. b SEPs from the same patient showing “Giant” cortical potentials and C-reflexes indicating
cortical hyperexcitability and stimulus sensitive myoclonus. c JLA for the same patient from the left upper arm. There is a biphasic,
positive/negative, spiky transient preceding by few milliseconds the rectified and averaged myoclonic EMG discharges (960 sweeps were
averaged). The cortico-muscular latencies are shown at a slower sweep time in the relevant Additional file 1. APB = abductor pollicis
brevis, BB=Biceps brachii, FCU = flexor carpi ulnaris, EDC = extensor digitorum communis, JLA = jerk-locked averaging, SEP = somatosensory
evoked potentials, TB = triceps brachii
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Discussion
Lithium remains a widely used effective treatment for
bipolar disorders [33] but its long-term use is associ-
ated with significant side effects, including renal, endo-
crine, dermatological and neurological manifestations
[32]. Neurotoxicity can sometimes be irreversible and
can occur after overdose or during maintenance treat-
ment with lithium levels within the therapeutic range
[34]. One of the most common side effects, reported in
up to 25%, is tremor primarily affecting the hands [5].
Tremor commonly appears early on in the course of
treatment and may improve over time. The tremor is
reportedly indistinguishable from essential or enhanced
physiologic tremor and patients typically do not have
features of Parkinsonism [1]. Lithium induced tremor is
more common in the elderly, possibly because of in-
creased prevalence of essential tremor in this age group
and, hence, the latter could be a predisposing factor.
Furthermore, male gender, concurrent antidepressant
(predominantly tricyclic antidepressants) and/or neuro-
leptic medications, higher doses of lithium with high
serum levels, caffeine intake, alcohol withdrawal and
anxiety are contributing factors [1, 3–5, 35–37] for the
development of tremor.
The pathophysiological characteristics of lithium
tremor remain poorly defined and is not yet clear if
presentation in the early versus late phases of treat-
ment exhibits distinguishing features. However, a
coarse irregular hand tremor together with symptoms
of ataxia, nystagmus, dysarthria and confusion is very
suggestive of lithium toxicity [3, 38]. Lithium induced
tremor may consist of rhythmical oscillations but it has
also been described as an irregular, non-rhythmical
tremor of variable intensity and frequency [6]. This
later description renders clinical distinction between
tremor and myoclonus problematic even if the latter
is commonly characterised by an irregular, jerky ap-
pearance [39].
Fig. 2 Results of JLA for 4 of the cases that were gluten positive (a), (b), (c), (d). A sharp biphasic transient appears in the contralateral central (a
and b) and in the contralateral frontocentral EEG channel preceding the onset of the averaged EMG discharges in (c and d). The cortico-muscular
latencies are shown at a slower sweep time in the relevant Additional file 1. APB = abductor pollicis brevis, BB=Biceps brachii, FCU = flexor carpi
ulnaris, EDC = extensor digitorum communis, JLA = jerk-locked averaging, SEP = somatosensory evoked potentials, TB = triceps brachii
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Myoclonus can be an adverse side effect of lithium
monotherapy [11] or in combination with other drugs
such as neuroleptics e.g. clozapine [40], and tricyclic anti-
depressants [41]. The presence of enlarged SEPs in pa-
tients receiving antidepressants in addition to lithium
raises suspicion that the myoclonus is cortically driven
[41]. This hypothesis was confirmed for a single case
where the technique of JLA was applied in a patient where
lithium with an antidepressant were prescribed [42].
A previous publication described five cases with cor-
tical action myoclonus while on treatment with lithium
(one also receiving antidepressant medications – sertra-
line and nefazodone) with no signs of neurotoxicity or
epileptiform abnormalities on their routine EEGs [43].
Only one of the cases, on lithium monotherapy, showed
enlarged SEPs.
Diffuse slow wave activity and epileptiform discharges
are typical EEG findings of lithium toxicity [44]. How-
ever, no significant background slowing was seen in any
of the EEGs of our patients with only occasional focal
epileptiform discharges in one but no obvious associ-
ation to the myoclonus. Overall, there was no significant
electroencephalographic evidence to suggest lithium
neurotoxicity in any of our cases, in keeping with the
normal serum levels of the drug.
A synergistic effect of different factors appears to be
contributing to the development of cortical myoclonus.
Firstly, prolonged exposure to lithium (7 to 40 years).
Secondly additional treatment with various types of anti-
depressant medications. Thirdly, 4 of the seven cases
with myoclonus had gluten sensitivity, a factor linked to
cerebellar ataxia and/or cortical myoclonus [21, 45–48].
Even allowing for the small size of our cohort, 57% had
gluten sensitivity when compared to 11% in the general
population [49]. Despite no evidence of lithium toxicity in
any of our cases, six out of the seven patients with cortical
myoclonus were female. Previous observations show that
toxicity, that includes a variety of symptoms in addition to
tremor, is more frequent amongst women [50, 51]. It is
therefore possible that female gender may be another pre-
disposing factor. Alcohol may also be another contributory
factor perhaps through causing cerebellar degeneration as
seen in two of our patients [52]. The underlying disease
process may also be contributory: There is evidence of
Fig. 3 Electrophysiological findings from case 6. a EEG/EMG polygraphy showing on a 1 s epoch the irregular myoclonic jerks, consisting of small
duration EMG discharges < 50 ms, demonstrating frequent co-activation of forearm antagonists with occasional simultaneous co-contraction of
intrinsic hand muscles. b Averaged data obtained with the technique of CC with the tremorogenic activity from the R EDC used as reference
(note the auto-correlation for the R EDC is 1). Spiky biphasic transients appear in the contralateral frontocentral EEG channel preceding the peak
of the autocorrelation findings from the EDC by a few milliseconds. Two minutes of this jerky activity were used on the analysis. Please note the
dotted lines indicate the 95% confidence interval. The cortico-muscular latencies are shown at a slower sweep time in the relevant Additional file
1. ADM = abductor digiti minimi, APB = abductor pollicis brevis, FCU = flexor carpi ulnaris, EDC = extensor digitorum communis
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dysfunction on fMRI scans, involving timing networks, that
include the cerebellar vermis in patients with psychosis
[53], further supporting previous evidence of vermian atro-
phy in psychiatric patients [54]. In addition, it has been
shown that patients with psychotic bipolar disorder dem-
onstrate dysconnectivity of selective cerebro-cerebellar net-
works not attributed to the effect of medication or other
substance use [55]. It is therefore possible that many of the
psychiatric patients on treatment with lithium have an in-
herent cerebellar vulnerability that could be aggravated by
chronic exposure to lithium.
The single patient with non-myoclonic tremor had a
strong family history of tremor and received additional
antipsychotic medication, both being predisposing factors
for the development of tremor. Despite the patient having
no features of parkinsonism his tremor was asymmetric,
Fig. 4 a CC analysis of the right arm tremor polygraphy recordings from case 8. This reveals typical sinusoidal oscillations at a frequency of
around 6 Hz with a mainly out of phase relationship between antagonist muscles in the forearm (FCU/EDC) and out of phase activation between
proximal and distal muscles. The right FCU was used as reference (i). FFT analysis (blocks of 4096 data points at a resolution of 0.5 Hz) was
implemented on the EMG recordings while maintaining antigravity posture; it reveals a tremor at 5.9 Hz with its first harmonic (ii). Same analysis
after loading the hand initially with 0.5Kg (iii) and then with 1 kg (iv) does not show any modification to the peak frequency of the tremor, as
expected for a centrally driven tremor. The electrophysiological findings from Case 8, shown in (a) versus another patient with cortical myoclonic
tremor, case 7 shown in (b). The arrows show the contralateral to EMG biphasic cortical transients on the averaged EEG data in the central areas.
The EMG polygraphy shows co-activation of proximal and distal muscles (i). The horizontal dotted lines in the central derivations represent the
95% confidence interval; the biphasic cortical transient preceding by few milliseconds the peak of the autocorrelation from the EDC is outside the
95% margins (ii). The cortico-muscular latencies for case 7 are shown at a slower sweep time in the relevant Additional file 1. Noticeably, the
cross-correlation analysis in a and b show the regular sinusoidal oscillations in the former, typically seen in tremors, and in the latter, the
synchronous proximal and distal activation that can be expected in cortically driven myoclonus. ADM = abductor digiti minimi, APB = abductor
pollicis brevis, BB = biceps brachii, Del = deltoid, FCU = flexor carpi ulnaris, EDC = extensor digitorum communis, TB = triceps brachii, Tra = trapezius
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involving mainly the right side, and tended to persist at
rest. Electrophysiology (Fig. 4) showed that this regular 6
Hz tremor had features of a centrally driven tremor that
would fit within the spectrum of essential tremor.
In all five cases where MRS was performed there was
evidence of cerebellar dysfunction whilst the electro-
physiological findings were suggesting a cortical gener-
ator of the myoclonic tremor. This is very much in
keeping with pathological findings from other conditions
where a phenotype of cortical myoclonic tremor is associ-
ated with cerebellar dysfunction, namely familial cortical
tremor with epilepsy (FCTE) and progressive myoclonus
ataxia (PMA) in coeliac disease [27, 48, 56–59]. Autopsy
results on families affected by FCTE and on individual
cases with PMA, shows that pathology is localising to the
cerebellum [48, 56–58]. While the cortex appears intact,
the electrophysiological findings show consistently a cor-
tical generator while the SEPs are typically “Giant” with or
without evidence of stimulus sensitive myoclonus (i.e.
cortical reflexes, “c-reflexes”). It is postulated that reduced
inhibition of the motor cortex due to dysfunctional cere-
bellar output results in cortical hyperexcitability [57],
however, only one of our seven patients with cortical myo-
clonus had giant SEPs.
Despite the fact that lithium treatment was stopped in
one of our patients and halved in another, this did not
translate into clinical improvement of their myoclonus.
This very limited evidence suggests that cortical myoclo-
nus may be an irreversible adverse effect of lithium when
there is superimposed pathology affecting the cerebellum.
Only one patient experienced improvement of her myo-
clonus on a gluten free diet, without any changes on the
lithium daily dose. The same patient showed improvement
of cerebellar functioning on MRS. Overall the myoclonic
tremor encountered in these patients is debilitating and
difficult to treat. We have used levetiracetam successfully
in cases of cortical myoclonus due to other aetiologies but
we have been reluctant to use this drug in this group of
patients with susceptibility to depression and behavioural
issues. Furthermore, most of these patients were already
on many psychotropic drugs.
Conclusions
We provide electrophysiological evidence of cortical myo-
clonus in seven patients presenting with an upper limb
tremor after long-term exposure to lithium. We identified
cerebellar dysfunction as being very prevalent in this
cohort. We postulate that factors affecting cerebellar func-
tion are crucial for the emergence of myoclonus in the
context of prolonged lithium exposure. Without appropri-
ate polygraphy recordings, differentiating between lithium
induced tremor and cortical myoclonus is not possible.
Lithium induced cortical myoclonus may not be as rare as
the paucity of published cases suggests.
Additional file
Additional file 1: “Cortico-muscular latencies” for 7 cases shown in
Figures S1, S2, S3 and S4. (PDF 2500 kb)
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